Download PDF
Thromb Haemost 2015; 113(06): 1357-1369
DOI: 10.1160/TH14-03-0286
Stroke, Systemic or Venous Thromboembolism
Schattauer GmbH

Efficacy and spatial distribution of ultrasound-mediated clot lysis in the absence of thrombolytics

Azzdine Y. Ammi
1   Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon, USA
,
Jonathan R. Lindner
1   Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon, USA
,
Yan Zhao
1   Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon, USA
,
Thomas Porter
2   Division of Cardiology, University of Nebraska, Omaha, Nebraska, USA
,
Robert Siegel
3   Cardiology Division, Cedars Sinai Medical Center, Los Angeles, California, USA
,
Sanjiv Kaul
1   Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon, USA
› Author Affiliations
Further Information

Publication History

Received: 14 April 2014

Accepted after major revision: 17 January 2015

Publication Date:
18 November 2017 (online)

    Permissions and Reprints

Summary

Ultrasound and microbubble (MB) contrast agents accelerate clot lysis, yet clinical trials have been performed without defining optimal acoustic conditions. Our aim was to assess the effect of acoustic pressure and frequency on the extent and spatial location of clot lysis. Clots from porcine blood were created with a 2-mm central lumen for infusion of lipid-shelled perfluorocarbon MBs (1×107 ml-1) or saline. Therapeutic ultrasound at 0.04, 0.25, 1.05, or 2.00 MHz was delivered at a wide range of peak rarefactional acoustic pressure amplitudes (PRAPAs). Ultrasound was administered over 20 minutes grouped on-off cycles to allow replenishment of MBs. The region of lysis was quantified using contrast-enhanced ultrasound imaging. In the absence of MBs, sonothrombolysis did not occur at any frequency. Sonothrombolysis was also absent in the presence of MBs despite their destruction at 0.04 and 2.00 MHz. It occurred at 0.25 and 1.05 MHz in the presence of MBs for PRAPAs > 1.2 MPa and increased with PRAPA. At 0.25 MHz the clot lysis was located in the far wall. At 1.05 MHz, however, there was a transition from far to near wall as PRAPA was increased. The area of clot lysis measured by ultrasound imaging correlated with that by micro-CT and quantification of debris in the effluent. In conclusion, sonothrombolysis with MBs was most efficient at 0.25 MHz. The spatial location of sonothrombolysis varies with pressure and frequency indicating that the geometric relation between therapeutic probe and vascular thrombosis is an important variable for successful lysis clinically.

Supported by grant (NIH R01-HL-095868).

Keywords

Thrombolysis / thrombolytic agents - ultrasound analysis - imaging
 

  • References

  • 1 Sobbe A. et al. Thrombolysis by ultrasound. Die Ultraschallauflösung von Thromben 1974; 52: 1117-1121.
    PubMedGoogle Scholar
  • 2 Luo H. et al. Transcutaneous ultrasound augments lysis of arterial thrombi in vivo. Circulation 1996; 94: 775-778.
    CrossrefPubMedGoogle Scholar
  • 3 Nishioka T. et al. Dissolution of thrombotic arterial occlusion by high intensity, low frequency ultrasound and dodecafluoropentane emulsion: An in vitro and in vivo study. J Am Coll Cardiol 1997; 30: 561-568.
    CrossrefPubMedGoogle Scholar
  • 4 Huai L. et al. Enhancement of thrombolysis in vivo without skin and soft tissue damage by transcutaneous ultrasound. Thromb Res 1998; 89: 171-177.
    CrossrefPubMedGoogle Scholar
  • 5 Birnbaum Y. et al. Noninvasive in vivo clot dissolution without a thrombolytic drug: Recanalization of thrombosed iliofemoral arteries by transcutaneous ultrasound combined with intravenous infusion of microbubbles. Circulation 1998; 97: 130-134.
    CrossrefPubMedGoogle Scholar
  • 6 Miyamoto T. et al. Coronary vasodilation by noninvasive transcutaneous ultrasound: An in vivo canine study. J Am Coll Cardiol 2003; 41: 1623-1627.
    CrossrefPubMedGoogle Scholar
  • 7 Rosenschein U. et al. Analysis of coronary ultrasound thrombolysis endpoints in acute myocardial infarction (ACUTE trial): Results of the feasibility phase. Circulation 1997; 95: 1411-1416.
    CrossrefPubMedGoogle Scholar
  • 8 Alexandrov AV. et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. New Engl J Med 2004; 351: 2170-2178.
    CrossrefPubMedGoogle Scholar
  • 9 Daffertshofer M. et al. Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia: Increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator – Results of a phase II clinical trial. Stroke 2005; 36: 1441-1446.
    CrossrefPubMedGoogle Scholar
  • 10 Alexandrov AV, Barlinn K. Taboos and opportunities in sonothrombolysis for stroke. Int J Hyperthermia 2012; 28: 397-404.
    CrossrefPubMedGoogle Scholar
  • 11 Pfaffenberger S. et al. Ultrasound thrombolysis. Thromb Haemost 2005; 94: 26-36.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Soltani A. et al. Sonothrombolysis: An Emerging Modality for the Treatment of Acute Ischemic and Hemorrhagic Stroke. Transl Stroke Res 2011; 02: 159-170.
    CrossrefPubMedGoogle Scholar
  • 13 Molina CA. et al. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. Stroke 2006; 37: 425-429.
    CrossrefPubMedGoogle Scholar
  • 14 Dinia L. et al. Reperfusion after stroke sonothrombolysis with microbubbles may predict intracranial bleeding. Neurology 2009; 73: 775-780.
    CrossrefPubMedGoogle Scholar
  • 15 Kutty S. et al. Sonothrombolysis of intra-catheter aged venous thrombi using microbubble enhancement and guided three-dimensional ultrasound pulses. J Am Soc Echocardiogr 2010; 23: 1001-1006.
    CrossrefPubMedGoogle Scholar
  • 16 Pagola J. et al. Timing of recanalization after microbubble-enhanced intravenous thrombolysis in basilar artery occlusion. Stroke 2007; 38: 2931-2934.
    CrossrefPubMedGoogle Scholar
  • 17 Weller GER. et al. Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. Cancer Res 2005; 65: 533-539.
    PubMedGoogle Scholar
  • 18 Rubiera M. et al. Do Bubble Characteristics Affect Recanalization in Stroke Patients Treated with Microbubble-Enhanced Sonothrombolysis?. Ultrasound Med Biol 2008; 34: 1573-1577.
    CrossrefPubMedGoogle Scholar
  • 19 Leeman JE. et al. Effect of Acoustic Conditions on Microbubble-Mediated Microvascular Sonothrombolysis. Ultrasound Med Biol 2012; 38: 1589-1598.
    CrossrefPubMedGoogle Scholar
  • 20 Datta S. et al. Ultrasound-Enhanced Thrombolysis Using Definity® as a Cavitation Nucleation Agent. Ultrasound Med Biol 2008; 34: 1421-1433.
    CrossrefPubMedGoogle Scholar
  • 21 Prokop AF. et al. Cavitational Mechanisms in Ultrasound-Accelerated Fibrinolysis. Ultrasound Med Biol 2007; 33: 924-933.
    CrossrefPubMedGoogle Scholar
  • 22 Shi WT. et al. Investigation of effectiveness of microbubble stable cavitation in thrombolysis. IEEE Ultrasonics Symposium 2010; 330-333.
    PubMedGoogle Scholar
  • 23 Chuang YH. et al. Effects of ultrasound-induced inertial cavitation on enzymatic thrombolysis. Ultrasonic Imag 2010; 32: 81-90.
    CrossrefPubMedGoogle Scholar
  • 24 Mizushige K. et al. Enhancement of ultrasound-accelerated thrombolysis by echo contrast agents: Dependence on microbubble structure. Ultrasound Med Biol 1999; 25: 1431-1437.
    CrossrefPubMedGoogle Scholar
  • 25 Chen SC. et al. In vitro evaluation of ultrasound-assisted thrombolysis using a targeted ultrasound contrast agent. Ultrasonic Imag 2010; 31: 235-246.
    PubMedGoogle Scholar
  • 26 Chen H. et al. Observations of translation and jetting of ultrasound-activated microbubbles in mesenteric microvessels. Ultrasound Med Biol 2011; 37: 2139-2148.
    CrossrefPubMedGoogle Scholar
  • 27 Chen H. et al. Microbubble dynamics in microvessels: Observations of microvessel dilation, invagination and rupture. IEEE Ultrasonics Symposium 2008; 1163-1166.
    PubMedGoogle Scholar
  • 28 Fong SW. et al. Numerical analysis of a gas bubble near bio-materials in an ultrasound field. Ultrasound Med Biol 2006; 32: 925-942.
    CrossrefPubMedGoogle Scholar
  • 29 Postema M. et al. High-speed photography during ultrasound illustrates potential therapeutic applications of microbubbles. Med Phys 2005; 32: 3707-3711.
    CrossrefPubMedGoogle Scholar
  • 30 Sankin GN, Zhong P. Interaction between shock wave and single inertial bubbles near an elastic boundary. Phys Rev E 2006; 74: 046304.
    CrossrefPubMedGoogle Scholar
  • 31 Devcic-Kuhar B. et al. Ultrasound affects distribution of plasminogen and tissue-type plasminogen activator in whole blood clots in vitro. Thromb Haemost 2004; 92: 980-985.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 32 Pfaffenberger S. et al. 2 MHz ultrasound enhances t-PA-mediated thrombolysis: Comparison of continuous versus pulsed ultrasound and standing versus travelling acoustic waves. Thromb Haemost 2003; 89: 583-589.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 33 Nedelmann M. et al. Low-frequency ultrasound induces nonenzymatic thrombolysis in vitro. J Ultrasound Med 2002; 21: 649-656.
    CrossrefPubMedGoogle Scholar
  • 34 Petit B. et al. In Vitro Sonothrombolysis of Human Blood Clots with BR38 Microbubbles. Ultrasound Med Biol 2012; 38: 1222-1233.
    CrossrefPubMedGoogle Scholar
  • 35 Caskey CF. et al. Microbubble tunneling in gel phantoms. J Acoust Soc Am 2009; 125: EL183-EL9.
    PubMedGoogle Scholar
  • 36 Acconcia C. et al. Investigating the interaction between acoustically stimulated microbubbles and fibrin clots. AIP Confer Proc 2012; 1503: 250-255.
    PubMedGoogle Scholar
  • 37 Wu J. et al. Improved Sonothrombolysis from a Modified Diagnostic Transducer Delivering Impulses Containing a Longer Pulse Duration. Ultrasound Med Biol. 2014. Epub ahead of print.
    Google Scholar
  • 38 Sutton JT. et al. Clot Retraction Affects the Extent of Ultrasound-Enhanced Thrombolysis in an Ex Vivo Porcine Thrombosis Model. Ultrasound Med Biol 2013; 39: 813-824.
    CrossrefPubMedGoogle Scholar
  • 39 Hitchcock KE. et al. Ultrasound-Enhanced rt-PA Thrombolysis in an ex vivo Porcine Carotid Artery Model. Ultrasound Med Biol 2011; 37: 1240-1251.
    CrossrefPubMedGoogle Scholar
  • 40 Tiukinhoy-Laing SD. et al. Ultrasound-facilitated thrombolysis using tissueplasminogen activator-loaded echogenic liposomes. Thromb Res 2007; 119: 777-784.
    CrossrefPubMedGoogle Scholar
  • 41 Altar S. et al. Augmentation of in-vitro clot dissolution by low frequency highintensity ultrasound combined with antiplatelet and antithrombotic drugs. J Thromb Thrombolysis 2001; 11: 223-228.
    CrossrefPubMedGoogle Scholar
  • 42 Hua X. et al. Construction of thrombus-targeted microbubbles carrying tissue plasminogen activator and their in vitro thrombolysis efficacy: A primary research. J Thromb Thrombol 2010; 30: 29-35.
    CrossrefPubMedGoogle Scholar
  • 43 Wu Y. et al. Binding and lysing of blood clots using MRX-408. Invest Radiol 1998; 33: 880-885.
    CrossrefPubMedGoogle Scholar
  • 44 Wang B. et al. Thrombolysis effect of a novel targeted microbubble with low-frequency ultrasound in vivo. Thrombosis and Haemostasis 2008; 100: 356-361.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 45 Hagisawa K. et al. Thrombus-targeted perfluorocarbon-containing liposomal bubbles for enhancement of ultrasonic thrombolysis: In vitro and in vivo study. J Thromb Haemost 2013; 11: 1565-1573.
    CrossrefPubMedGoogle Scholar
  • 46 Xie F. et al. Treatment of Acute Intravascular Thrombi With Diagnostic Ultrasound and Intravenous Microbubbles. J Am Coll Cardiol : Cardiovascular Imag 2009; 02: 511-518.
    PubMedGoogle Scholar
  • 47 Xie F. et al. Detection of Intravascular Cavitational Activity during Treatment of Deep Vessel Thromboses with Diagnostic Ultrasound and Intravenous Microbubbles. Circulation Suppl 2007; 116: II–646.
    PubMedGoogle Scholar